ILMN
35
12
CTAS
45
2
COST
50
7
IFF
41
8
FMC
34
4
CSX
36
3
UNP
39
4
HIG
70
2
NAVI
29
4
SJM
19
3
M
17
3
AVY
53
5
HD
46
5
WMT
67
5
URI
53
3
KHC
36
7
EXR
48
6
WEC
75
3
AVGO
42
16
CMS
53
3
ILMN
35
12
CTAS
45
2
COST
50
7
IFF
41
8
FMC
34
4
CSX
36
3
UNP
39
4
HIG
70
2
NAVI
29
4
SJM
19
3
M
17
3
AVY
53
5
HD
46
5
WMT
67
5
URI
53
3
KHC
36
7
EXR
48
6
WEC
75
3
AVGO
42
16
CMS
53
3
Financhill
Back

Office Properties Income Trust Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
16

OPI
Office Properties Income Trust

Last Price:
$0.37
Seasonality Move:
-1.16%
Sell
27

CRSP
CRISPR Therapeutics AG

Last Price:
$37.78
Seasonality Move:
21.79%
Sell
16
Office Properties Income Trust (OPI) is a Sell

Is Office Properties Income Trust a Buy, Sell or Hold?

  • The current Office Properties Income Trust [OPI] share price is $0.37. The Score for OPI is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • OPI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $37.77. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPI Stock Price Chart

What is Office Properties Income Trust's stock price today?

  • The Office Properties Income Trust share price today is $0.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPI is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $37.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.

OPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 31.63 Sell
Chaikin Money Flow: 578227 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.35 - 0.63) Sell
Bollinger Bands (100): (0.59 - 1.25) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.36 Buy
Relative Strength Index (14 RSI): 49.46 Sell
Chaikin Money Flow: 99115 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.98 - 41.22) Buy
Bollinger Bands (100): (37.58 - 47.38) Sell

OPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Buy
20-day SMA: 0.43 Sell
50-day SMA: 0.7 Sell
200-day SMA: 1.5 Sell
8-day EMA: 0.36 Buy
20-day EMA: 0.45 Sell
50-day EMA: 0.65 Sell
200-day EMA: 1.55 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.63 Buy
20-day SMA: 36.55 Buy
50-day SMA: 40.9 Sell
200-day SMA: 46.21 Sell
8-day EMA: 36.89 Buy
20-day EMA: 32.04 Buy
50-day EMA: 20.78 Buy
200-day EMA: 6.95 Buy

Office Properties Income Trust Earnings Growth & OPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.51 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.91 per share.

Office Properties Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):